CN113929701A - Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof - Google Patents

Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof Download PDF

Info

Publication number
CN113929701A
CN113929701A CN202111208652.0A CN202111208652A CN113929701A CN 113929701 A CN113929701 A CN 113929701A CN 202111208652 A CN202111208652 A CN 202111208652A CN 113929701 A CN113929701 A CN 113929701A
Authority
CN
China
Prior art keywords
group
independently
compound
formula
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111208652.0A
Other languages
Chinese (zh)
Inventor
吴伟
孙刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Halation Photonics Corp
Original Assignee
Halation Photonics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Halation Photonics Corp filed Critical Halation Photonics Corp
Priority to CN202111208652.0A priority Critical patent/CN113929701A/en
Publication of CN113929701A publication Critical patent/CN113929701A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

The invention discloses a dithieno [2, 3-b; 3',2' -d]Thiophene derivatives and their use, the derivatives being compounds of the general formula J:
Figure DDA0003307951310000011
wherein m and m' independently of one another represent 0 or 1 or 2; n and n' independently of one another represent 0 or 1; rS1And RS2Independently of one another, an alkyl group having 1 to 12 carbon atoms, a cyclopentyl group, a cyclobutyl group or a cyclopropyl group, wherein in addition, one or more-CH groups which are not adjacent to each other in the alkyl group are present2The radicals may each be independently substituted by-C.ident.C-, -CH ═ CH-, -O-, -CO-, -COO-or-OCO-, and in which one or more H atoms may be substituted by F; and wherein one or more further H atoms may be substituted by F. The compounds are very useful for reducing the rotational viscosity gamma 1 of liquid crystal compositions for display applicationsBecomes faster and is also very suitable for increasing the dielectric anisotropy | Δ ∈ | of the liquid crystal composition to reduce the driving voltage for low power consumption display.

Description

Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof
Technical Field
The invention belongs to the field of liquid crystal materials, relates to a liquid crystal compound, and particularly relates to a dithieno [2, 3-b; 3',2' -d ] thiophene derivatives and their use.
Background
Liquid crystal displays are widely used in mobile phones, smart phones, notebook computers, tablet computers, monitors, televisions, public displays, billboards, vehicle-mounted displays, industrial displays, and the like. As the liquid crystal display technology mode, a Twisted Nematic (TN) mode, a Super Twisted Nematic (STN) mode, a Guest Host (GH) mode, an in-plane switching (IPS) mode, a Fringe Field Switching (FFS) mode, an Optically Compensated Birefringence (OCB) mode, a voltage controlled birefringence (ECB) mode, a Vertical Alignment (VA) mode, a Ferroelectric Liquid Crystal (FLC), and the like are mainly included. The liquid crystal display driving method mainly includes a static driving method, a multiplex driving method, a simple matrix method, and an Active Matrix (AM) method in which driving is performed by a Thin Film Transistor (TFT), a Thin Film Diode (TFD), or the like. Among them, displays such as IPS type, FFS type, ECB type, VA type, and the like exhibit favorable characteristics when a liquid crystal composition having negative dielectric anisotropy (Δ ∈) (negative liquid crystal composition) is used.
Patent documents CN 105153112B, CN110831931, CN106045953A disclose a 4, 6-difluoro-dibenzothiophene derivative, patent documents CN101343279B and Journal of Organic Chemistry (2006),71(8),3264 disclose dithieno [2, 3-B; although the preparation method of 3',2' -d ] thiophene can be used in the field of liquid crystal, Tni and other parameters have poor performance and have limitation in application. In addition, the liquid crystal compounds have many defects in clearing point, low-temperature storage property, and the like.
Disclosure of Invention
In view of the disadvantages of the prior art, it is an object of the present invention to provide compounds which can be used as components of liquid-crystal compositions, in particular, which have a negative dielectric anisotropy Δ ∈, a high clearing point Tni, a low γ 1, and a low overall parameter γ 1/| Δ |, and which are particularly suitable for the simultaneous advantageous optimization of the individual application parameters of the liquid-crystal compositions. The method is particularly suitable for FFS, IPS and VA displays.
In order to achieve the purpose, the invention adopts the following technical scheme:
the present invention provides a compound of formula J:
Figure BDA0003307951300000011
wherein m and m' independently of one another represent 0 or 1 or 2; n and n' independently of one another represent 0 or 1;
RS1and RS2Independently of one another, an alkyl group having 1 to 12 carbon atoms, a cyclopentyl group, a cyclobutyl group or a cyclopropyl group, wherein in addition, one or more-CH groups which are not adjacent to each other in the alkyl group are present2The radicals may each be independently substituted by-C.ident.C-, -CH ═ CH-, -O-, -CO-, -COO-or-OCO-, and in which one or more H atoms may be substituted by F;
namely, RS1And RS2Independently of one another, an alkyl group having 1 to 12 carbon atoms, a cyclopentyl group, a cyclobutyl group or a cyclopropyl group; or, RS1And RS2Independently of one another, an alkyl group having 1 to 12 carbon atoms, a cyclopentyl group, a cyclobutyl group or a cyclopropyl group, wherein one or more-CH groups not adjacent to each other in the alkyl group are present2-each independently is substituted with-C ≡ C-, -CH ═ CH-, -O-, -CO-, -COO-, or-OCO-; or, RS1And RS2Independently of one another, represents alkyl having 1 to 12 carbon atoms, cyclopentyl, cyclobutyl or cyclopropyl, wherein one or more H atoms of these radicals are substituted by F; or, RS1And RS2Independently of one another, an alkyl group having 1 to 12 carbon atoms, a cyclopentyl group, a cyclobutyl group or a cyclopropyl group, wherein one or more-CH groups not adjacent to each other in the alkyl group are present2-each independently is substituted with-C ≡ C-, -CH ═ CH-, -O-, -CO-, -COO-, or-OCO-, and one or more H atoms in these groups are substituted with F;
AS1and AS2Independently of one another, represent a group (i.e. a), b), c) selected from:
a)1, 4-phenylene in which one or two CH groups may be replaced by N and in which one or more H atoms may be replaced by a group L;
that is, a) is 1, 4-phenylene; or, 1, 4-phenylene in which one or two CH groups are replaced by N; or, 1, 4-phenylene in which one or more H atoms are replaced by a group L; or, 1, 4-phenylene in which one or two CH groups are replaced by N and in which one or more H atoms are replaced by a group L;
b) from the group consisting of trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene, one or more of themA non-adjacent CH2The groups may be replaced by-O-and/or-S-, and wherein one or more H atoms may be replaced by F;
that is, b) is a group consisting of trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene; or, b) is a group consisting of trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene, wherein one or more non-adjacent CH groups2The radicals being replaced by-O-and/or-S-; or, b) is a group consisting of trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene, wherein one or more H atoms are replaced by F; or, b) is a group consisting of trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene, wherein one or more non-adjacent CH groups2The radicals being replaced by-O-and/or-S-, and wherein one or more H atoms are replaced by F;
c) a group consisting of tetrahydropyran-2, 5-diyl, 1, 3-dioxane-2, 5-diyl, tetrahydrofuran-2, 5-diyl, cyclobutane-1, 3-diyl, piperidine-1, 4-diyl, silole-2, 5-diyl, thiophene-2, 5-diyl and selenophene-2, 5-diyl, each of which may be further mono-or polysubstituted with an L group;
that is, c) is a group consisting of tetrahydropyran-2, 5-diyl, 1, 3-dioxane-2, 5-diyl, tetrahydrofuran-2, 5-diyl, cyclobutane-1, 3-diyl, piperidine-1, 4-diyl, silole-2, 5-diyl, thiophene-2, 5-diyl and selenophene-2, 5-diyl; or, c) is a group consisting of tetrahydropyran-2, 5-diyl, 1, 3-dioxan-2, 5-diyl, tetrahydrofuran-2, 5-diyl, cyclobutane-1, 3-diyl, piperidine-1, 4-diyl, silole-2, 5-diyl, thiophene-2, 5-diyl and selenophene-2, 5-diyl, each of which is further mono-or polysubstituted by a group L;
the L groups independently represent F, Cl, CN, SCN, SF5Or straight-chain or branched, in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12C atoms;
ZS1and ZS2Independently of one another represent-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CO)O-、-O(CO)-、-CH2CH2-、-CF2-CF2-、-CF2-CH2-、-CH2-CF2-、-CH=CH-、-CF=CF-、-CF=CH-、-CH=CF-、-C≡C-、-O-、-S-。
Preferably, RS1And RS2Independently of one another, represent unsubstituted alkyl having 1 to 9 carbon atoms, or alkenyl, alkenyloxy having 2 to 8 carbon atoms, in each case optionally one or more H atoms may be substituted by F.
In formula J, the parameter m is preferably 0 or 1, m 'is preferably 0 or 1, and the sum of m + m' is preferably 1;
the sum of the parameters n + n' is preferably 0 or 1; the sum of the parameters n + n' is preferably 1;
RS1and RS2Preferably each independently of the others, represents an alkyl radical having 1 to 8 carbon atoms or an alkenyl radical having 2 to 8 carbon atoms, respectively, where RS1And RS2The groups are preferably different;
RS1and RS2Further preferably each independently of the other represents an alkyl radical having in each case 2 to 8C atoms, where RS1And RS2The groups are preferably different.
In the general formula J, AS1And AS2Preferably independently represent a group selected from:
Figure BDA0003307951300000031
Figure BDA0003307951300000032
further preferred is from
Figure BDA0003307951300000033
Figure BDA0003307951300000034
ZS1Preferably represents-O-, -S-, -CH2O-or-CF2O-;
ZS2Preferably represents-O-, -S-, -OCH2-or-OCF2-;
L preferably represents F, Cl, -CF3Or an alkyl or alkoxy group having 1, 2 or 3 carbon atoms.
Further preferred, the compound of formula J is selected from the group consisting of sub-formulae J-1, J-2, J-3 and J-4:
Figure BDA0003307951300000041
in the formula, RS1、RS2、AS1、ZS1Have the meaning as defined above for the general formula J.
Further preferred, the compound of sub-formula J-1 is preferably selected from compounds of formulae J-1-1 to J-1-11:
Figure BDA0003307951300000042
Figure BDA0003307951300000051
in the formula, RS1、RS2Have the meaning as defined above for the general formula J.
Further preferred, the compound of sub-formula J-2 is preferably selected from compounds of formulae J-2-1 to J-2-10:
Figure BDA0003307951300000061
Figure BDA0003307951300000071
in the formula, RS1、RS2Have the meaning as defined above for the general formula J.
The compounds have a clearly negative dielectric anisotropy (. DELTA.. di-elect cons.) and are therefore particularly suitable for liquid-crystalline compositions for VA, FFS, IPS-TFT displays. The compounds according to the invention preferably have a value of Δ ε.ltoreq.5, more preferably Δ ε.ltoreq.8 and particularly preferably Δ ε.ltoreq.12. They show good miscibility with conventional substances used in liquid crystal compositions for displays, i.e. they have good solubility therein. In addition the rotational viscosity of the compounds and the resulting liquid crystal compositions is also advantageously low.
Other physical, physicochemical or electrooptical parameters of the compounds according to the invention are also advantageous for the use of the compounds in liquid-crystalline compositions. Liquid crystal compositions comprising these compounds have in particular a wide nematic phase range and good low temperature and long-term stability as well as a sufficiently high clearing point. The low melting point of the compounds according to the invention indicates a favorable mixing behavior of the composition.
The following reference schemes illustrate particularly suitable synthetic routes for the compounds according to the invention. In the following scheme, the substituent RS1、RS2Have the meaning as described for the formula J.
Figure BDA0003307951300000081
The reaction schemes shown above should be considered as illustrative only. The skilled person will be able to carry out corresponding variations of the presented syntheses, and also follow other suitable synthetic routes to obtain compounds of general formula J. The present invention also includes, in one embodiment, one or more methods of preparing compounds of formula J according to the synthetic schemes depicted above.
The compounds of formula J can be used in liquid crystal compositions.
The liquid crystal composition is a liquid crystal composition comprising at least two liquid crystal compounds, and the liquid crystal compounds comprise at least one compound with a general formula J.
Compared with the prior art, the invention has the following beneficial effects:
3, 4-difluoro-dithieno [2, 3-b; 3',2' -d]Thiophene derivatives can be used as components of liquid crystal compositions having negative dielectric anisotropy (Delta)ε), exhibit large birefringence (Δ n), small rotational viscosity (γ 1), high clearing point (Tni), low overall parameter γ 1/| Δ ε |. Wherein A isS1、AS2The group can optimize Tni to improve the working temperature width performance, ZS1、ZS2The group can improve the compatibility in the composition and show more excellent low-temperature storage performance. The compound is very suitable for reducing the rotational viscosity gamma 1 of the liquid crystal composition to enable the response speed of display application to be faster, and is also very suitable for improving the dielectric anisotropy | delta epsilon | of the liquid crystal composition to reduce the driving voltage to realize low-energy consumption display. In addition, the liquid crystal composition has excellent compatibility, long low-temperature storage time, easy adjustment of high Tni and wide working temperature range. The method is particularly suitable for FFS, IPS and VA displays.
Detailed Description
The technical solution of the present invention is further explained by the following embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
The starting materials are commercially available from the open literature unless otherwise specified.
According to the conventional detection method in the field, various performance parameters of the liquid crystal compound are obtained through linear fitting, wherein the specific meanings of the performance parameters are as follows:
Δ n: refractive index anisotropy at 25 degrees Celsius (C.);
Δ ε: dielectric anisotropy at 25 degrees Celsius (C.);
γ 1: rotational viscosity (mPas) at 25 ℃ (. degree.C.).
Tni: clearing point (. degree. C.), temperature at which the nematic phase of the liquid crystal changes to the isotropic phase.
Low temperature storage (-30 ℃): the liquid crystal composition containing 10% of the compound of the present invention was stored at-30 ℃ for a continuous storage time in which no crystallization (precipitation) was observed.
Δ ∈, Δ n, γ 1, Tni of the compounds according to the invention were obtained by linear extrapolation of a liquid-crystal mixture consisting of 5 to 10% of the respective compound according to the invention and 90 to 95% of a liquid-crystal composition precursor mixed in a total amount of 100%.
Example 1
This example provides a compound, 3, 4-difluoro-dithieno [2, 3-b; 3',2' -d ] thiophene derivative J-1-4(TM 1):
Figure BDA0003307951300000091
the synthesis of compound J-1-4(TM1) was as follows:
step 1:
Figure BDA0003307951300000101
2-Methoxythiophene (Compound 1) (30g, 0.262mol) was dissolved in n-pentanol (80mL) and toluene (60mL), and NaHSO was added4(1g) After refluxing with mixing and distilling off an azeotrope of methanol and toluene (12mL), the residue was washed with a sodium carbonate solution, dried and fractionally distilled to give 2-n-pentyloxythiophene compound 2(36g) in 77% yield.
Step 2:
Figure BDA0003307951300000102
2-n-pentyloxythiophene (Compound 2) (48g, 0.27mol) was dissolved in 125mL of methylene Chloride (CH)2Cl2) N-bromosuccinimide (NBS, 96g, 0.54mol) was added under argon protection at 10 ℃ and stirred to react for 1 hour, the reaction solution was transferred to a chloroform solution to be washed with water, the organic phase was dried, and the residue was subjected to silica gel column chromatography to isolate compound 3(102.9g) in 90% yield after distilling the solvent.1H-NMR(400MHz;CDCl3;25℃)δ=0.99(s,3H),δ=1.39(s,4H),δ=1.77(s,2H),δ=4.05(s,2H),6.40(s,1H)ppm。
And step 3:
Figure BDA0003307951300000103
compound 3(23.5g, 70mmol) was dissolved in 150mL of anhydrous tetrahydrofuran (THT), 48mL of a 1.6N-butyllithium (N-BuLi, 80mmol, 1.1eq.) solution in diethyl ether was gradually added dropwise at-78 ℃ under argon protection, and the reaction was stirred at this temperature for 1 hour, then 10.7mL of trimethylsilicon chloride (80mmol, 1.1eq.) was added at this temperature and reacted at the same temperature for 1 hour. After the reaction solution was returned to room temperature, 300ml of water was added and the organic phase was extracted with 150ml of X3 ether, and after drying and evaporation of the solvent, a crude product was obtained which was analyzed by silica gel column chromatography to obtain Compound 4(16.57g) in a yield of 72%.1H-NMR(400MHz;CDCl3;25℃)0.27(s,9H),δ=0.90(s,3H),δ=1.39(s,4H),δ=1.77(s,2H),δ=4.05(s,2H),6.59(s,1H)ppm;FAB-MS m/z:320(M+)。
And 4, step 4:
Figure BDA0003307951300000104
compound 4(21.2g, 66mmol) was dissolved in 250ml of anhydrous tetrahydrofuran (THT), 41ml of a solution of 1.6N-butyllithium (N-BuLi, 68.9mmol, 1.05eq.) in diethyl ether was gradually added dropwise at-78 ℃ under argon protection, and the reaction was stirred at this temperature for 1 hour. Then adding fluorinating agent (PhSO)2)2NF (21.7g, 68.8mmol) and reacted at-78 deg.C for 30 min. And (3) after the reaction solution returns to the room temperature, adding HCl solution for quenching, washing and extracting, separating an organic phase, evaporating the solvent from the organic phase to obtain a crude product, and performing silica gel column chromatography analysis to obtain the compound 5(16.5) with the yield of 78%. 1H-NMR (400 MHz; CDCl)3;25℃)0.31(9H,s),δ=0.90(s,3H),δ=1.39(s,4H),δ=1.77(s,2H),δ=4.05(s,2H),6.40(s,1H)ppm;FAB-MS m/z:260(M+)。
And 5:
Figure BDA0003307951300000111
compound 5(30g, 0.115mol)) Dissolved in 100mL of methylene Chloride (CH)2Cl2) N-bromosuccinimide (NBS, 20.5g, 0.115mol) was added under argon protection at 10 ℃ and stirred to react for 1 hour, the reaction solution was transferred to a chloroform solution and washed with water, the organic phase was dried, and the residue was subjected to silica gel column chromatography after distilling the solvent to isolate compound 6(35.8g) in 92% yield.1H-NMR(400MHz;CDCl3;25℃)0.32(9H,s),δ=0.90(s,3H),δ=1.39(s,4H),δ=1.77(s,2H),δ=4.05(s,2H)ppm;FAB-MS m/z:338(M+)。
Step 6:
Figure BDA0003307951300000112
compound 6(20g, 59mmol) was dissolved in 60mL of dichloromethane (CH)2Cl2) To the reaction solution, Trifluoroacetic acid (TFA, 5mL) was added dropwise thereto, and the reaction was stirred at room temperature for 10min, quenched with water, and then the organic phase was extracted, washed with water, dried, and the solvent was distilled off to obtain compound 7(15.5g) in 99% yield. 1H-NMR (400 MHz; CDCl)3;25℃)δ=0.90(s,3H),δ=1.39(s,4H),δ=1.77(s,2H),δ=4.05(s,2H),δ=6.05(s,1H)ppm;FAB-MS m/z:266(M+)。
And 7:
Figure BDA0003307951300000113
compound 7(27g, 101mmol) was dissolved in 100ml of anhydrous tetrahydrofuran (THT), 60ml of a 1.6N-butyllithium (N-BuLi, 110mmol, 1.1eq.) solution in diethyl ether was gradually added dropwise at-78 ℃ under argon atmosphere, and the reaction was stirred at this temperature for 1 hour, after which Bu was added at this temperature3SnCl (29.5mL, 110mmol, 1.1eq.) and the reaction stirred at the same temperature for 1 hour. The reaction solution was returned to room temperature and then quenched with water, and the organic phase was extracted, washed with water, dried, and concentrated to give compound 8(40.6g) in 85% yield. 1H-NMR (400 MHz; CDCl)3;25℃)0.90-0.92(m,12H),δ=1.33-1.39(m,10H),δ=1.58-1.63(m,12H),δ=1.77(s,2H),δ=4.05(s,2H),6.40(s,1H)ppm;FAB-MS m/z:478(M+)。
And 8:
Figure BDA0003307951300000121
compound 8(15g, 31.4mmol) and 3-fluoro-4-bromo-thiophene (4.74g, 26.2mol) and Pd (PPh)3)2Cl2(541mg, 0.771mmol) was dissolved in 30mL of anhydrous DMF solvent, the reaction was stirred at 80 ℃ under argon for 3 hours, and after the reaction solution was cooled to room temperature, aqueous KF solution was added and stirred overnight. Extraction, washing with water, drying and passing through n-hexane silica gel column gave compound 9(6.8g) in 90% yield.1H-NMR(400MHz;CDCl3;25℃)0.90(s,3H),δ=1.39(m,4H),δ=1.77(s,2H),δ=4.05(s,2H),6.35(s,1H),6.67(s,1H),7.78(s,1H)ppm;FAB-MS m/z:288(M+)。
And step 9:
Figure BDA0003307951300000122
compound 9(28.8g, 0.100mol) was dissolved in 100mL of methylene Chloride (CH)2Cl2) N-bromosuccinimide (NBS, 35.7g, 0.200mol) was added under argon protection at 10 ℃ and stirred to react for 1 hour, the reaction solution was transferred to a chloroform solution and washed with water, the organic phase was dried, and the residue was subjected to silica gel column chromatography after distilling the solvent to isolate compound 10(43.7g) with a yield of 98%.1H-NMR(400MHz;CDCl3;25℃)0.90(s,3H),δ=1.39(m,4H),δ=1.77(s,2H),δ=4.05(s,2H),6.56(s,1H)ppm;FAB-MS m/z:446(M+)。
Step 10:
Figure BDA0003307951300000131
compound 10(4.46g, 10mmol) was dissolved in 50ml of anhydrous ether, the temperature was lowered to-78 ℃, t-butyllithium (t-BuLi,23mmol), reacting at-78 deg.C for 2 hr, and adding anhydrous (PhSO)2)2S (10.5mmol), the temperature was slowly raised to room temperature, and the mixture was stirred overnight. Adding water to quench the reaction, adding ether for extraction, combining organic phases, adding saturated NaCl, washing by distilled water and drying to obtain a crude product. The crude product was isolated by silica gel column chromatography to give Compound 11(1.9g) in 60% yield.1H-NMR(400MHz;CDCl3;25℃)0.90-0.97(m,6H),δ=1.38-1.47(m,6H),δ=1.74-1.77(m,4H),δ=4.05(s,4H)ppm;FAB-MS m/z:318(M+)。
Step 11:
Figure BDA0003307951300000132
compound 11(31.8g, 0.100mol) was dissolved in 100mL of dichloromethane (CH2Cl2), N-bromosuccinimide (NBS, 35.7g, 0.200mol) was added under argon shielding at 10 ℃ and the reaction was stirred for 1 hour, the reaction solution was transferred to a chloroform solution and washed with water, the organic phase was dried, and the residue after distillation of the solvent was subjected to silica gel column chromatography to isolate compound 10(39g) in 98% yield.1H-NMR(400MHz;CDCl3;25℃)0.90(s,3H),δ=1.39(m,4H),δ=1.77(s,2H),δ=4.05(s,2H)ppm;FAB-MS m/z:396(M+)。
Step 12:
Figure BDA0003307951300000133
compound 12(8g, 0.020mol), p-3-n-propylphenylboronic acid (3.3g), PdCl2(PPh3)2(0.1g),K2CO3(5.5g)60mL of DMF, 20mL of deionized water, and heating under argon for 3 hours. The reaction mixture was washed with water, the organic phase was dried, the solvent was distilled off, and the residue was subjected to silica gel column chromatography to give Compound J-1-4(TM1) (7.0g) in 80% yield1H-NMR(400MHz;CDCl3;25℃)0.90-0.94(m,6H),δ=1.39(m,4H),δ=1.64(s,2H),δ=1.77(s,2H),δ=2.61(s,2H),δ=4.05(s,2H),δ=7.32(s,2H),δ=7.77(s,2H)ppm;FAB-MS m/z:436(M+)。
The performance parameters of J-1-4(TM1) were Δ ∈ -10.5, Δ n ═ 0.211, and rotational viscosity (γ 1) ═ 115.
Example 2
The following compounds were prepared in analogy to the synthetic procedure of example 1:
Figure BDA0003307951300000141
the performance parameters are Δ ∈ -11, Δ n ═ 0.201, and rotational viscosity (γ 1) ═ 119.
Example 3
The following compounds were prepared in analogy to the synthetic procedure of example 1:
Figure BDA0003307951300000142
the performance parameters are Tni equal to 105 ℃, Δ ∈ -7, Δ n equal to 0.220, rotational viscosity (γ 1) equal to 103, γ 1/| Δ ∈ | equal to 14.7, and low-temperature storage time (-30 ℃): 360 hr.
Example 4
The following compounds were prepared in analogy to the synthetic procedure of example 1:
Figure BDA0003307951300000143
the performance parameters are Tni ═ 112 ℃, Δ ∈ ═ 10.5, Δ n ═ 0.188, rotational viscosity (γ 1) ═ 95, γ 1/| Δ ∈ | > 9.04, and low-temperature storage time (-30 ℃): 360 hr.
Example 5
The following compounds were prepared in analogy to the synthetic procedure of example 1:
Figure BDA0003307951300000144
the performance parameters are Tni ═ 108 ℃, Δ ∈ ═ 15, Δ n ═ 0.195, rotational viscosity (γ 1) ═ 132, γ 1/| Δ | _ 8.8, and low-temperature storage time (-30 ℃): 360 hr.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.

Claims (10)

1. A compound characterized by having, in a first aspect,
the compound is of the general formula J:
Figure FDA0003307951290000011
wherein m and m' independently of one another represent 0 or 1 or 2; n and n' independently of one another represent 0 or 1;
RS1and RS2Independently of one another, an alkyl group having 1 to 12 carbon atoms, a cyclopentyl group, a cyclobutyl group or a cyclopropyl group, wherein in addition, one or more-CH groups which are not adjacent to each other in the alkyl group are present2The-groups may each be independently substituted by-C ≡ C-, -CH ═ CH-, -O-, -CO-, -COO-or-OCO-, and wherein one or more H atoms may be substituted by F.
AS1And AS2Independently of one another, represent a group selected from:
a)1, 4-phenylene in which one or two CH groups may be replaced by N and in which one or more H atoms may be replaced by a group L;
b) trans-1, 4-cyclohexylene and 1, 4-cyclohexenylene, in which one or more non-adjacent CH groups2The groups may be replaced by-O-and/or-S-, and wherein one or more H atoms may be replaced by F;
c) from tetrahydropyran-2, 5-diyl, 1, 3-diyl
Figure FDA0003307951290000012
Alkane-2, 5-bisA group consisting of a tetrahydrofuran-2, 5-diyl group, a cyclobutane-1, 3-diyl group, a piperidine-1, 4-diyl group, a silol-2, 5-diyl group, a thiophene-2, 5-diyl group and a selenophene-2, 5-diyl group, each of which may be further mono-or polysubstituted with an L group;
the L groups independently represent F, Cl, CN, SCN, SF5Or straight-chain or branched, in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12C atoms;
ZS1and ZS2Independently of one another represent-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CO)O-、-O(CO)-、-CH2CH2-、-CF2-CF2-、-CF2-CH2-、-CH2-CF2-、-CH=CH-、-CF=CF-、-CF=CH-、-CH=CF-、-C≡C-、-O-、-S-。
2. The compound of claim 1,
RS1and RS2Independently of one another, represent unsubstituted alkyl having 1 to 9 carbon atoms, or alkenyl, alkenyloxy having 2 to 8 carbon atoms, in each case optionally one or more H atoms may be substituted by F.
3. The compound of claim 1,
the parameter m is 0 or 1, m 'is 0 or 1 and the sum of m + m' is 1;
the sum of the parameters n + n' is 0 or 1;
RS1and RS2Each independently of the other represents an alkyl radical having 1 to 8 carbon atoms or an alkenyl radical having 2 to 8 carbon atoms, where RS1And RS2The groups are preferably different;
in the general formula J, AS1And AS2Independently represent a group selected from:
Figure FDA0003307951290000021
ZS1represents-O-, -S-, -CH2O-or-CF2O-;
ZS2represents-O-, -S-, -OCH2-or-OCF2-;
L represents F, Cl, -CF3Or an alkyl or alkoxy group having 1, 2 or 3 carbon atoms.
4. A compound according to claim 3,
the sum of the parameters n + n' is 1;
RS1and RS2Each independently of the other represents an alkyl radical having 2 to 8C atoms, where RS1And RS2The groups are preferably different.
5. A compound according to claim 3,
in the general formula J, AS1And AS2Independently represent a group selected from:
Figure FDA0003307951290000022
6. the compound according to any one of claims 1 to 5,
the compound of formula J is selected from the group consisting of sub-formulae J-1, J-2, J-3, and J-4:
Figure FDA0003307951290000023
Figure FDA0003307951290000031
in the formula, RS1、RS2、AS1、ZS1Has the same as the above forThe meaning as defined for formula J.
7. The compound of claim 6,
compounds of sub-formula J-1 are preferably selected from compounds of formulae J-1-1 to J-1-11:
Figure FDA0003307951290000032
Figure FDA0003307951290000041
in the formula, RS1、RS2Have the meaning as defined above for the general formula J.
8. The compound of claim 6,
the compound of sub-formula J-2 is preferably selected from compounds of formulae J-2-1 to J-2-10:
Figure FDA0003307951290000042
Figure FDA0003307951290000051
in the formula, RS1、RS2Have the meaning as defined above for the general formula J.
9. Use of one or more of the compounds according to any of claims 1 to 8 in liquid crystal compositions.
10. Use according to claim 9, wherein the liquid crystal composition is a liquid crystal composition comprising at least two liquid crystal compounds comprising at least one compound of formula J.
CN202111208652.0A 2021-10-18 2021-10-18 Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof Pending CN113929701A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111208652.0A CN113929701A (en) 2021-10-18 2021-10-18 Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111208652.0A CN113929701A (en) 2021-10-18 2021-10-18 Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof

Publications (1)

Publication Number Publication Date
CN113929701A true CN113929701A (en) 2022-01-14

Family

ID=79280205

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111208652.0A Pending CN113929701A (en) 2021-10-18 2021-10-18 Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof

Country Status (1)

Country Link
CN (1) CN113929701A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114752394A (en) * 2022-04-29 2022-07-15 苏州汉朗光电有限公司 Negative large-birefringence liquid crystal composition and application thereof
CN115386385A (en) * 2022-08-15 2022-11-25 重庆汉朗精工科技有限公司 Negative liquid crystal composition and preparation method and application thereof
WO2024089216A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Novel sulfur-containing heteroaryl carboxamide compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDRE A. KIRYANOV等: "Synthesis and mesomorphic properties of 1,1-difluoroalkylsubstituted biphenylthienyl and terphenyl liquid crystals. A comparative study of mesomorphic behavior relative to alkyl, alkoxy and alkanoyl analogs", 《J. MATER. CHEM.》 *
PAVEL S. GRIBANOV等: "Stannylation of Aryl Halides, Stille Cross-Coupling, and One-Pot, Two-Step Stannylation/Stille Cross-Coupling Reactions under Solvent-Free Conditions", 《EUR. J. ORG. CHEM.》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114752394A (en) * 2022-04-29 2022-07-15 苏州汉朗光电有限公司 Negative large-birefringence liquid crystal composition and application thereof
CN115386385A (en) * 2022-08-15 2022-11-25 重庆汉朗精工科技有限公司 Negative liquid crystal composition and preparation method and application thereof
WO2024089216A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Novel sulfur-containing heteroaryl carboxamide compounds

Similar Documents

Publication Publication Date Title
CN109134423B (en) Compound, liquid crystal composition thereof and photoelectric display device
TWI461514B (en) Thiophene derivatives, and lc media comprising same
KR101675175B1 (en) Thiophene derivatives and liquid crystal media containing the same
CN113929701A (en) Dithieno [2, 3-b; 3',2' -d ] thiophene derivative and application thereof
CN107011920B (en) Liquid-crystalline medium comprising thiophene derivatives
TWI541236B (en) Liquid-crystalline medium comprising stabiliser
CN107207965B (en) Nematic liquid crystal composition and liquid crystal display element using same
TW201620892A (en) 4,6-difluorodibenzothiophene derivatives
KR20150108325A (en) 4,6-difluorodibenzofuran derivatives
CN111465592B (en) Compound, liquid crystal composition and liquid crystal display element
JP2006008660A (en) Fluorinated heterocyclic compound and use of the same in liquid crystal mixture
JPH0291080A (en) Organosylylalkyl-or sylylalkenyl-compound, its production and use thereof in liquid crystal mixture
KR101676034B1 (en) Liquid-crystal compounds and lc media
US7026021B2 (en) Fluorinated heterocycles and their use in liquid-crystal mixtures
KR100971340B1 (en) Perfluoroallyloxy compound and liquid-crystal composition containing the compound
EP3874009A1 (en) Dibenzofuran and dibenzothiophene derivatives
TWI530492B (en) Liquid-crystalline medium and liquid-crystal display
CN113773334A (en) 3, 5-difluoro-dithieno [3,2-b:2',3' -d ] thiophene derivative and application thereof
US20050098762A1 (en) Fluorinated polycycles and their use in liquid-crystal mixtures
CN113788841A (en) 3, 5-difluoro-dithieno [3,2-b:2',3' -d ] thiophene derivative and application thereof
JP4989858B2 (en) Fluorinated xanthines and their use in liquid crystal mixtures
CN113717195A (en) 3, 4-difluoro-dithieno [2,3-b; 3',2' -d ] thiophene derivative and application thereof
CN113527242A (en) Liquid crystal compound, liquid crystal composition thereof and liquid crystal display device
JP4735928B2 (en) Liquid crystalline compound and liquid crystal composition having 6-membered ring lactone skeleton
CN104884575B (en) Liquid crystal media

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20220114